Gary E. Raskob, Ph.D., is Senior Vice President and Provost at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, with overall responsibility for the educational and research programs of its seven colleges, and the Stephenson Cancer Center and the Harold Hamm Diabetes Center. He also serves on the Boards of the OU Health system and the University Hospitals Authority and Trust, the Oklahoma City Chamber, and United Way of Central Oklahoma.
Dr. Raskob has academic appointments in the College of Public Health, and the College of Medicine, as a Regents Professor of Epidemiology and Medicine. He began his career at the OU Health Sciences Center in 1991. His research and scholarly interests are in the prevention and treatment of deep-vein thrombosis and pulmonary embolism; clinical trials and antithrombotic drug development; evidence-based medicine and public health; and the translation of research evidence into practice.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO). He also served as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC). He was the inaugural Chair of the Steering Committee for the World Thrombosis Day initiative of the International Society in Thrombosis and Haemostasis (ISTH), from 2013 through 2019, and he currently serves on the Board of Directors for the National Blood Clot Alliance (NBCA), the major patient advocacy organization in the United States for patients with venous thrombosis and pulmonary embolism. He is author or co-author of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 21 articles in the New England Journal of Medicine.
Dr. Raskob is a past Chair of the Board of Directors for the Association of Schools and Programs of Public Health, the organization which represents more than 100 universities in the US and globally with accredited schools and programs in public health. He is an immediate past Chair of the Oklahoma City-County Board of Health, which has oversight responsibility for the health department serving the 1.3 million residents of Oklahoma City-County.
Dr. Raskob received his PhD in pharmaceutical sciences from the University of Oklahoma, a Master of Science (MSc) degree in clinical epidemiology and health research methodology from McMaster University in Hamilton, Canada, and a Bachelor of Science degree in pharmacology from the University of Toronto, Canada.